An Open Label N of 1 Study to Evaluate the Safety and Efficacy of Long-Term Treatment with Ivacaftor in Combination with ALTALUREN (PTCD124) In Subjects with Nonsense Mutation Cystic Fibrosis

Grant

Total Award Amount

  • 51500.00
  • Direct Costs

  • 46818.00
  • Sponsor Award Id

  • MDBR-16-120-CF1282x
  • Contributor

  • msolomon   Investigator  
  • ranger   Investigator  
  • smrowe   Principal Investigator